Home | Welcome to Contract Pharma   
Last Updated Thursday, July 24 2014
Print RSS Feed

Breaking News

Gil Roth
January 6, 2014
Alkermes, DiaVacs, Kala, Oxygen Biotherpeutics, Peregrine, TauRx  Read More »
Kristin Brooks
January 3, 2014
Allows researchers to access sponsor clinical data  Read More »
Kristin Brooks
January 3, 2014
Alexar Therapeutics to develop portfolio of Liver X receptor (LXR) agonists  Read More »
Kristin Brooks
January 3, 2014
Mirna gains additional rights to lead program  Read More »
Kristin Brooks
January 3, 2014
Expands development and manufacturing for cell therapy product portfolio  Read More »
Kristin Brooks
January 3, 2014
Lead molecule and back-up compounds offer potential in cancer/inflammatory diseases  Read More »
Kristin Brooks
January 3, 2014
Ranker and Ho join the board  Read More »
Kristin Brooks
January 3, 2014
Bamzai to head commercial ops in India  Read More »
Kristin Brooks
January 2, 2014
Phase II Tosedostat trials in blood cancer resume  Read More »
Kristin Brooks
January 2, 2014
Expands healthcare service portfolio and market presence  Read More »
Kristin Brooks
January 2, 2014
To advance DNA-based therapeutics for Friedreich's ataxia  Read More »
Kristin Brooks
January 2, 2014
Files ANDA for generic topical with global partner  Read More »
Kristin Brooks
December 30, 2013
Gains two OTC women’s health products  Read More »
Kristin Brooks
December 30, 2013
Aims to advance drug for Marburg virus through Phase I  Read More »
Kristin Brooks
December 30, 2013
Once-daily formulation offers potential in kidney transplants   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On